ITP patient characteristics
| Patient no. . | Age, y . | Sex . | Platelet count, ×109/L . | Antiplatelet antibody target . | Major previous drugs . | Bleeding symptoms . | |
|---|---|---|---|---|---|---|---|
| GPIIb/IIIa . | GPIb/IX . | ||||||
| 1 | 41 | F | 12 | + | − | Steroid, VCR | EC, EP |
| 2 | 46 | M | 18 | + | − | Steroid, IVIg, eltrombopag | EC |
| 3 | 22 | F | 6 | − | + | Steroid, RTX | EC, GH |
| 4 | 37 | F | 25 | + | − | Steroid, rhTPO | EC, PT |
| 5 | 28 | M | 22 | + | − | Steroid, rhTPO, IVIg | EC, PT |
| 6 | 33 | M | 5 | + | + | Steroid, rhTPO, RTX | EC, GH |
| 7 | 45 | F | 32 | − | − | Steroid, IVIg, rhTPO, RTX | PT |
| 8 | 52 | F | 14 | − | + | Steroid, VCR | PT, EC |
| 9 | 35 | F | 20 | + | − | Steroid, RTX, eltrombopag | EC |
| 10 | 60 | M | 31 | + | − | Steroid, rhTPO | GH |
| 11 | 40 | F | 19 | − | − | IVIg, steroid | EC |
| 12 | 23 | M | 17 | + | − | Steroid, RTX | EC |
| 13 | 65 | F | 21 | − | + | IVIg, steroid, rhTPO | EP |
| 14 | 47 | M | 16 | + | − | Steroid, RTX, danazol | GH, EP |
| 15 | 29 | F | 8 | + | + | Steroid, RTX | GUH, EP |
| 16 | 25 | M | 23 | − | − | Steroid, IVIg, rhTPO, RTX | PT |
| 17 | 32 | M | 3 | + | + | Steroid, IVIg, rhTPO, RTX | EC, PT, GH |
| 18 | 42 | F | 15 | − | + | Steroid, danazol, RTX | PT |
| 19 | 38 | F | 8 | + | − | Steroid, splenectomy, RTX | EP |
| 20 | 50 | M | 10 | + | − | IVIg, rhTPO, steroid | PT |
| 21 | 57 | M | 7 | + | − | Steroid, thalidomide, CsA | EC, PT |
| 22 | 40 | F | 11 | − | + | Steroid, VCR | EC, GH |
| 23 | 72 | F | 23 | + | − | Steroid | GH |
| 24 | 45 | M | 36 | − | − | Steroid, RTX | EC |
| 25 | 59 | F | 12 | − | + | None | EC, PT |
| 26 | 48 | F | 19 | + | − | Steroid, RTX, rhTPO | EP |
| 27 | 55 | M | 22 | − | − | None | PT |
| 28 | 31 | F | 25 | − | + | IVIg, rhTPO | GH, PT |
| 29 | 52 | M | 15 | + | − | Steroid, RTX, rhTPO | EC, PT |
| 30 | 28 | F | 21 | + | + | Steroid, rhTPO | GUH, EC |
| 31 | 33 | M | 9 | + | − | Steroid, RTX, CsA | PT |
| 32 | 56 | F | 11 | − | + | Steroid, IVIg | EC, EP, PT |
| Patient no. . | Age, y . | Sex . | Platelet count, ×109/L . | Antiplatelet antibody target . | Major previous drugs . | Bleeding symptoms . | |
|---|---|---|---|---|---|---|---|
| GPIIb/IIIa . | GPIb/IX . | ||||||
| 1 | 41 | F | 12 | + | − | Steroid, VCR | EC, EP |
| 2 | 46 | M | 18 | + | − | Steroid, IVIg, eltrombopag | EC |
| 3 | 22 | F | 6 | − | + | Steroid, RTX | EC, GH |
| 4 | 37 | F | 25 | + | − | Steroid, rhTPO | EC, PT |
| 5 | 28 | M | 22 | + | − | Steroid, rhTPO, IVIg | EC, PT |
| 6 | 33 | M | 5 | + | + | Steroid, rhTPO, RTX | EC, GH |
| 7 | 45 | F | 32 | − | − | Steroid, IVIg, rhTPO, RTX | PT |
| 8 | 52 | F | 14 | − | + | Steroid, VCR | PT, EC |
| 9 | 35 | F | 20 | + | − | Steroid, RTX, eltrombopag | EC |
| 10 | 60 | M | 31 | + | − | Steroid, rhTPO | GH |
| 11 | 40 | F | 19 | − | − | IVIg, steroid | EC |
| 12 | 23 | M | 17 | + | − | Steroid, RTX | EC |
| 13 | 65 | F | 21 | − | + | IVIg, steroid, rhTPO | EP |
| 14 | 47 | M | 16 | + | − | Steroid, RTX, danazol | GH, EP |
| 15 | 29 | F | 8 | + | + | Steroid, RTX | GUH, EP |
| 16 | 25 | M | 23 | − | − | Steroid, IVIg, rhTPO, RTX | PT |
| 17 | 32 | M | 3 | + | + | Steroid, IVIg, rhTPO, RTX | EC, PT, GH |
| 18 | 42 | F | 15 | − | + | Steroid, danazol, RTX | PT |
| 19 | 38 | F | 8 | + | − | Steroid, splenectomy, RTX | EP |
| 20 | 50 | M | 10 | + | − | IVIg, rhTPO, steroid | PT |
| 21 | 57 | M | 7 | + | − | Steroid, thalidomide, CsA | EC, PT |
| 22 | 40 | F | 11 | − | + | Steroid, VCR | EC, GH |
| 23 | 72 | F | 23 | + | − | Steroid | GH |
| 24 | 45 | M | 36 | − | − | Steroid, RTX | EC |
| 25 | 59 | F | 12 | − | + | None | EC, PT |
| 26 | 48 | F | 19 | + | − | Steroid, RTX, rhTPO | EP |
| 27 | 55 | M | 22 | − | − | None | PT |
| 28 | 31 | F | 25 | − | + | IVIg, rhTPO | GH, PT |
| 29 | 52 | M | 15 | + | − | Steroid, RTX, rhTPO | EC, PT |
| 30 | 28 | F | 21 | + | + | Steroid, rhTPO | GUH, EC |
| 31 | 33 | M | 9 | + | − | Steroid, RTX, CsA | PT |
| 32 | 56 | F | 11 | − | + | Steroid, IVIg | EC, EP, PT |
+ indicates antiplatelet antibody positive; − indicates antiplatelet antibody negative.
CsA, cyclosporin; EC, ecchymoses; EP, epistaxis; F, female; GH, gingival hemorrhage; GP, glycoprotein; GUH, genitourinary hemorrhage; IVIg, IV γ-globulin; M, male; PT, petechiae; rhTPO, recombinant human thrombopoietin; RTX, rituximab; VCR, vincristine.